Physician profile
Kenneth A Lee
NPI 1063040574
$1,554.47
in general payments reported to CMS, 2019-2025
17 companies · $896 in 2025
The $896 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $153 · 2024: $506 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $368.31 | 2023-2025 | |
| Pfizer INC. | $202.47 | 2023-2025 | |
| Lilly USA, LLC | $182.03 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $129.02 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $118.08 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $116.72 | 2024-2025 | Repatha, Otezla, Otezla |
| Exact Sciences Corporation | $91.03 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $80.27 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Neos Therapeutics, LP | $66.42 | 2025 | Adzenys Xr-Odt |
| Bayer Healthcare Pharmaceuticals INC. | $39.40 | 2025 | |
| Phathom Pharmaceuticals, INC. | $32.02 | 2024 | Voquezna |
| Inspire Medical Systems, INC. | $30.16 | 2025 | Inspire |
| Optinose US, INC. | $27.73 | 2025 | |
| Abbott Laboratories | $22.50 | 2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.30 | 2025 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.54 | 2023 | Eliquis |
| Currax Pharmaceuticals LLC | $13.47 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.